| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 6 |
| 1 | GABAPENTIN | 6 |
| 2 | OLAPARIB | 6 |
| 3 | ADALIMUMAB | 5 |
| 4 | EFAVIRENZ | 5 |
| 5 | LAMIVUDINE | 5 |
| 6 | LAMIVUDINE ORAL | 5 |
| 7 | LEVOTHYROXINE SODIUM | 5 |
| 8 | ETANERCEPT | 4 |
| 9 | NEVIRAPINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 1 | POTASSIUM IODIDE | 1 | 0.0007 |
| 2 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 3 | EFAVIRENZ | 5 | 0.0005 |
| 4 | NEVIRAPINE | 4 | 0.0004 |
| 5 | MARAVIROC | 1 | 0.0004 |
| 6 | OLAPARIB | 6 | 0.0003 |
| 7 | DICLOFENAC EPOLAMINE | 1 | 0.0002 |
| 8 | VERAPAMIL HYDROCHLORIDE | 1 | 0.0002 |
| 9 | PENTOXIFYLLINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Folate Analog [EPC] | 3 | 0.0001 |